S&P 500
$5,802.82
-0.7%
-$39.19
DJI
$41,603.07
-0.6%
-$256.02
NASDAQ
$18,737.21
-1.0%
-$188.53
Bitcoin
107,615.00
-1.0%
-1,134.67
AAPL
$195.55
-2.9%
-$5.81
AMZN
$201.33
-0.9%
-$1.77
GOOG
$169.68
-1.3%
-$2.30
META
$627.70
-1.4%
-$8.87
MSFT
$451.11
-0.8%
-$3.75
NVDA
$131.48
-1.0%
-$1.36
TSLA
$339.93
-0.3%
-$1.11
Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights
Mar 25, 2025
by Keith Speights
Investing in Genetic Sequencing Stocks
Mar 25, 2025
by Keith Speights
Investing in Marijuana Stocks
Mar 24, 2025
by Keith Speights
Could a Recession Affect Medicare?
Mar 23, 2025
by Keith Speights
Is Summit Therapeutics a Millionaire Maker?
![Trump at White House podium. Official White House Photo by D. Myles Cullen. [MConverter.eu]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F811740%2Ftrump-at-white-house-podium-official-white-house-photo-by-d-myles-cullen-mconvertereu.jpg&op=resize&w=165&h=104)
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.